心肌梗死后1年稳定患者的长期死亡、心血管事件与出血风险:丹麦全国性研究
结果显示,随着指南推荐治疗使用率提高,患者5年粗死亡率、再发心梗及出血风险均显著下降(均P-trend<0.001),2015-17年<60岁患者5年死亡率低至2.6%。
要点
- 心梗后1年无事件稳定患者长期预后持续改善,5年死亡率从18.6%降至12.5%。
- 指南推荐治疗(他汀、PCI)使用率大幅提升,与预后改善相关。
- 2015-17年<60岁患者5年死亡率仅2.6%,风险低于既往报告。
核心结论
- 心梗后1年无事件患者长期死亡、心血管事件及出血风险显著下降,与指南推荐治疗使用改善同步。
主要发现
- 5年粗死亡率从18.6%(95%CI 17.9-19.2)降至12.5%(95%CI 11.9-13.1),再发心梗从7.5%(95%CI 7.1-8.0)降至5.5%(95%CI 5.1-6.0),出血从3.9%(95%CI 3.6-4.3)降至2.7%(95%CI 2.4-3.0),均P-trend<0.001。
- 2015-17年<60岁患者5年粗死亡率为2.6%。
- 对2000-02年数据按后期治疗分布标准化后,5年死亡风险为15.5%(95%CI 14.9-16.2)。
关键数值与推荐
- 指南推荐治疗使用率上升:他汀从68.6%至92.5%,经皮冠状动脉介入治疗从23.9%至68.2%。
临床怎么用
- 对心梗后1年无事件稳定患者,应持续优化指南推荐治疗以进一步降低长期死亡、再发心梗及出血风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Outcomes after myocardial infarction (MI) improved during recent decades alongside better risk factor management and implementation of guideline-recommended treatments. However, it is unknown whether this applies to stable patients who are event-free 1 year after MI. METHODS AND RESULTS: Using nationwide Danish registries, we included all patients with first-time MI during 2000-17 who survived 1 year free from bleeding and cardiovascular events (n = 82 108, median age 64 years, 68.2% male). Follow-up started 1 year after MI and continued through January 2022. Crude risks of mortality, cardiovascular events, and bleeding were estimated in consecutive 3-year periods. Standardized risks were calculated with respect to the distribution of age, sex, comorbidities, and treatments in the latter period. Guideline-recommended treatment use increased during the study period: e.g. statins (68.6-92.5%) and percutaneous coronary intervention (23.9-68.2%). The crude 5-year risks of outcomes decreased (all P-trend <0.001): Mortality, 18.6% (95% confidence interval [CI]: 17.9-19.2) to 12.5% (CI: 11.9-13.1); Recurrent MI, 7.5% (CI: 7.1-8.0) to 5.5% (CI: 5.1-6.0); Bleeding, 3.9% (CI: 3.6-4.3) to 2.7% (CI: 2.4-3.0). Crude 5-year risk of mortality in 2015-17 was as low as 2.6% for patients aged <60 years. Use of guideline-recommended treatments was associated with improved outcomes: After standardization for changes in treatments, 5-year risk of mortality in 2000-02 was 15.5% (CI: 14.9-16.2). CONCLUSIONS: For patients who were event-free 1 year after MI, the long-term risks of mortality, cardiovascular events, and bleeding decreased significantly, along with an improved use of guideline-recommended treatments between 2000 and 2017. In the most recent period, 1 year after MI, the risk of additional events was lower than previously reported.
引用
- Christensen, Schjerning, Smedegaard, et al. Long-term mortality, cardiovascular events, and bleeding in stable patients 1 year after myocardial infarction: a Danish nationwide study. Eur Heart J. 2023. PMID: 36433809. doi:10.1093/eurheartj/ehac667
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。